VivoSim Labs, Inc.
VIVS
$0.17-3.39%
End of day · as of Oct 13, 2026, 2:00 AM ET
Mkt cap
$3.50M
EV/Sales
-11.62
P/E ratio
N/A
FY2026 Revenue
$131,000
EPS (9mo ended 2025-12-31)
$-3.14
Gross Margin (FY2026)
N/A
Profit Margin (FY2026)
-10567.18%
Beta
N/A
Div yield
N/A
Sector
Healthcare
VivoSim Labs, Inc. (VIVS) is a biotechnology company listed on NASDAQ.
Latest reported VIVS revenue for 2026-03-31 was $131.0K. Net income was -$13.8M. Revenue was down 9.0% from 2025-03-31 to 2026-03-31. VIVS currently screens at market cap $3.5M.
Use this VIVS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full VIVS income, balance, and cash tables.
VivoSim Labs, Inc. (VIVS) is a biotechnology company in the Healthcare sector.
Latest cached VivoSim Labs, Inc. (VIVS) revenue for Mar 31, 2026 was $131.0K. Net income was -$13.8M. Statements: https://lician.com/financials/vivs
VivoSim Labs, Inc. (VIVS) market capitalization is $3.5M on the latest cached snapshot.
VivoSim Labs, Inc. (VIVS) cached previous close $0.18; day range $0.17 – $0.18; volume 1,078,097. Session quote: https://lician.com/quote/vivs
VivoSim Labs, Inc. (VIVS) latest cached earnings event is "VIVS earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached VIVS filing is 8-K · Oct 16, 2026. Filings: https://lician.com/sec/vivs